|Study Type:||Phase Ib|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1b clinical trial to evaluate the safety and immunogenicity of recombinant adenoviral serotype 35 (rAd35) and serotype 5 (rAd5) HIV-1 vaccines when given as a heterologous prime-boost regimen or as boosts to a recombinant DNA vaccine in healthy, Ad5-naive and Ad5-exposed, low risk, HIV-1 uninfected adult participants
HVTN 077 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of VRCHIVADV027-00-VP (rAd35), VRCHIVADV038-00-VP (rAd5), and VRC-HIVDNA044-00-VP (DNA).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.